Brigit Biofarmaka Teknologi Tbk. vs Gaya Abadi Sempurna Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 31.2K 24h volume), while Gaya Abadi Sempurna Tbk. trades at Rp105 (market cap 216.78B, 569.25M 24h volume). The key difference: Gaya Abadi Sempurna Tbk. is the larger of the two by market cap, and Gaya Abadi Sempurna Tbk. is more actively traded (569.25M versus 31.2K). Which is the better fit depends on your goals.
| OBAT | SLIS | |
|---|---|---|
Market Cap | 164.65B | 216.78B |
Volume | 31.2K | 569.25M |
Lot | 312 | 5.69M |
Turnover | 7.54M | 57.42B |
Average Price | 241.62 | 100.87 |
Value | 7.54M | 57.42B |
Indicative Equilibrium Price | 238 | 92 |
Indicative Equilibrium Volume | 100 | 156.49K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Gaya Abadi Sempurna Tbk. (The Company) was established based on Notarial Deed Soekaimi S.H., No. 155 dated September 26, 1996, Notary in Jakarta. The company have began its commercial operations since 1996.The Company’s holding entity and ultimate holding entity as of April 30, 2019 is PT Selis Investama Indonesia
Read more on SLIS →